Clinical Trial Update: Capecitabine in Women With Operable Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of capecitabine in women with operable breast cancer has been terminated, with limited details provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Invasive Breast Carcinoma, Primary Invasive Breast Cancer | Phase 2 | Status: TERMINATED